New Fund
New York City-based OrbiMed secured $3 billion to back life sciences and healthcare companies across the U.S., Europe, and Asia, spanning biopharmaceuticals, medical devices, diagnostics, and tech-enabled healthcare services.
Toronto, Canada-based Genesys Capital announced the second close of its...
Brooklyn, NY-based SEVA Growth closed a $160m second growth equity fund to...
<p>USA-based <a href="http://facktorhealth.com">Facktor Ventures</a>...
Boston-based Stride Consumer Partners closed a $550m fund to back...
New York City-based Solari Capital launched (size undisclosed) to invest...
Washington, DC-based Enable Ventures announced the final close of a...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.
